title: A novel homozygous p.Arg527Leu LMNA mutation in two unrelated Egyptian families causes overlapping mandibuloacral dysplasia and progeria syndrome.
abstract: Mandibuloacral dysplasia (MAD) is a rare disease resulting from a mutation of LMNA gene encoding lamins A and C. The most common mutation associated with this disease is a homozygous arginine 527 replacement by histidine. Three female patients originating from two unrelated families from Northeast Egypt were examined. Their growth was retarded; they had microcephaly, widened cranial sutures, prominent eyes and cheeks, micrognathia, dental crowding, hypoplastic mandible, acro-osteolysis of distal phalanges, and joint contractures. In addition, they presented some progeroid features, such as pinched nose, premature loss of teeth, loss of hair, scleroderma-like skin atrophy, spine rigidity, and waddling gait. The clinical presentation of the disease varied between the patient originating from Family 1 and patients from Family 2, suggesting that unknown, possibly epigenetic factors, modify the course of the disease. The first symptoms of the disease appeared at the age of 2.5 (a girl from Family 1), 5, and 3 years (girls from Family 2). All patients had the same, novel homozygous c.1580G>T LMNA mutation, resulting in the replacement of arginine 527 by leucine. Computational predictions of such substitution effects suggested that it might alter protein stability and increase the tendency for protein aggregation, and as a result, might influence its interaction with other proteins. In addition, restriction fragment-length polymorphism analysis performed in 178 unrelated individuals showed that up to 1.12% of inhabitants of Northeast Egypt might be heterozygous carriers of this mutation, suggesting the presence of a founder effect in this area.
authors.affiliation: Genetics Unit, Department of Pediatrics, Faculty of Medicine, Mansoura University Children's Hospital, Mansoura, Egypt. mail: m.alhaggar@yahoo.co.uk
authors.forename: Mohammad
authors.initials: M
authors.lastname: Al-Haggar
authors.forename: Agnieszka
authors.initials: A
authors.lastname: Madej-Pilarczyk
authors.forename: Lukasz
authors.initials: L
authors.lastname: Kozlowski
authors.forename: Janusz M
authors.initials: JM
authors.lastname: Bujnicki
authors.forename: Sohier
authors.initials: S
authors.lastname: Yahia
authors.forename: Dina
authors.initials: D
authors.lastname: Abdel-Hadi
authors.forename: Amany
authors.initials: A
authors.lastname: Shams
authors.forename: Nermin
authors.initials: N
authors.lastname: Ahmad
authors.forename: Sahar
authors.initials: S
authors.lastname: Hamed
authors.forename: Monika
authors.initials: M
authors.lastname: Puzianowska-Kuznicka
mesh_terms: D000015:Abnormalities, Multiple / Q000175:diagnosis / Q000235:genetics*; D001120:Arginine / Q000235:genetics; D002648:Child; D002675:Child, Preschool; D004534:Egypt / Q000453:epidemiology; D005260:Female; D018703:Founder Effect; D006579:Heterozygote; D006801:Humans; D034904:Lamin Type A / Q000235:genetics*; D007930:Leucine / Q000235:genetics; D008334:Mandible / Q000002:abnormalities*; D020125:Mutation, Missense; D010375:Pedigree; D012150:Polymorphism, Restriction Fragment Length; D011371:Progeria / Q000175:diagnosis / Q000235:genetics*; D055550:Protein Stability; D013577:Syndrome
chemical_list: C494847:LMNA protein, human; D034904:Lamin Type A; D001120:Arginine; D007930:Leucine